These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 14505915

  • 1. Mucosal antibody response induced with a nasal virosome-based influenza vaccine.
    Durrer P, Glück U, Spyr C, Lang AB, Zurbriggen R, Herzog C, Glück R.
    Vaccine; 2003 Oct 01; 21(27-30):4328-34. PubMed ID: 14505915
    [Abstract] [Full Text] [Related]

  • 2. Intranasal administration of a proteosome-influenza vaccine is well-tolerated and induces serum and nasal secretion influenza antibodies in healthy human subjects.
    Treanor J, Nolan C, O'Brien D, Burt D, Lowell G, Linden J, Fries L.
    Vaccine; 2006 Jan 16; 24(3):254-62. PubMed ID: 16129526
    [Abstract] [Full Text] [Related]

  • 3. Human immune responses elicited by an intranasal inactivated H5 influenza vaccine.
    Ainai A, van Riet E, Ito R, Ikeda K, Senchi K, Suzuki T, Tamura SI, Asanuma H, Odagiri T, Tashiro M, Kurata T, Multihartina P, Setiawaty V, Pangesti KNA, Hasegawa H.
    Microbiol Immunol; 2020 Apr 16; 64(4):313-325. PubMed ID: 31957054
    [Abstract] [Full Text] [Related]

  • 4. Local and systemic immune response in nursing-home elderly following intranasal or intramuscular immunization with inactivated influenza vaccine.
    Muszkat M, Greenbaum E, Ben-Yehuda A, Oster M, Yeu'l E, Heimann S, Levy R, Friedman G, Zakay-Rones Z.
    Vaccine; 2003 Mar 07; 21(11-12):1180-6. PubMed ID: 12559796
    [Abstract] [Full Text] [Related]

  • 5. Immunopotentiating of mucosal and systemic antibody responses in mice by intranasal immunization with HLT-combined influenza virosomal vaccine.
    Cusi MG, Lomagistro MM, Valassina M, Valensin PE, Glück R.
    Vaccine; 2000 Jun 15; 18(25):2838-42. PubMed ID: 10812227
    [Abstract] [Full Text] [Related]

  • 6. Strong local and systemic protective immunity induced in the ferret model by an intranasal virosome-formulated influenza subunit vaccine.
    Lambkin R, Oxford JS, Bossuyt S, Mann A, Metcalfe IC, Herzog C, Viret JF, Glück R.
    Vaccine; 2004 Oct 22; 22(31-32):4390-6. PubMed ID: 15474733
    [Abstract] [Full Text] [Related]

  • 7. Local and systemic isotype-specific antibody responses to equine influenza virus infection versus conventional vaccination.
    Nelson KM, Schram BR, McGregor MW, Sheoran AS, Olsen CW, Lunn DP.
    Vaccine; 1998 Aug 22; 16(13):1306-13. PubMed ID: 9682395
    [Abstract] [Full Text] [Related]

  • 8. Developments in mucosal influenza virus vaccines.
    Kuno-Sakai H, Kimura M, Ohta K, Shimojima R, Oh Y, Fukumi H.
    Vaccine; 1994 Nov 22; 12(14):1303-10. PubMed ID: 7856295
    [Abstract] [Full Text] [Related]

  • 9. IgA polymerization contributes to efficient virus neutralization on human upper respiratory mucosa after intranasal inactivated influenza vaccine administration.
    Terauchi Y, Sano K, Ainai A, Saito S, Taga Y, Ogawa-Goto K, Tamura SI, Odagiri T, Tashiro M, Fujieda M, Suzuki T, Hasegawa H.
    Hum Vaccin Immunother; 2018 Jun 03; 14(6):1351-1361. PubMed ID: 29425074
    [Abstract] [Full Text] [Related]

  • 10. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M, Velumani S, He F, Karuppannan AK, Geng GY, Yin LK, Kwang J.
    Virology; 2008 Oct 25; 380(2):412-20. PubMed ID: 18786689
    [Abstract] [Full Text] [Related]

  • 11. Intranasal vaccination with a replication-deficient influenza virus induces heterosubtypic neutralising mucosal IgA antibodies in humans.
    Morokutti A, Muster T, Ferko B.
    Vaccine; 2014 Apr 07; 32(17):1897-900. PubMed ID: 24560674
    [Abstract] [Full Text] [Related]

  • 12. Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection.
    Hong SH, Byun YH, Nguyen CT, Kim SY, Seong BL, Park S, Woo GJ, Yoon Y, Koh JT, Fujihashi K, Rhee JH, Lee SE.
    Vaccine; 2012 Jan 05; 30(2):466-74. PubMed ID: 22051136
    [Abstract] [Full Text] [Related]

  • 13. Intranasal Administration of Whole Inactivated Influenza Virus Vaccine as a Promising Influenza Vaccine Candidate.
    Ainai A, Suzuki T, Tamura SI, Hasegawa H.
    Viral Immunol; 2017 Jan 05; 30(6):451-462. PubMed ID: 28650274
    [Abstract] [Full Text] [Related]

  • 14. Intranasal vaccination with ISCOMATRIX adjuvanted influenza vaccine.
    Coulter A, Harris R, Davis R, Drane D, Cox J, Ryan D, Sutton P, Rockman S, Pearse M.
    Vaccine; 2003 Feb 14; 21(9-10):946-9. PubMed ID: 12547607
    [Abstract] [Full Text] [Related]

  • 15. Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?
    Tamura S, Ainai A, Suzuki T, Kurata T, Hasegawa H.
    Jpn J Infect Dis; 2016 Feb 14; 69(3):165-79. PubMed ID: 27212584
    [Abstract] [Full Text] [Related]

  • 16. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
    de Haan A, Haijema BJ, Voorn P, Meijerhof T, van Roosmalen ML, Leenhouts K.
    Vaccine; 2012 Jul 06; 30(32):4884-91. PubMed ID: 22537989
    [Abstract] [Full Text] [Related]

  • 17. A novel dry powder influenza vaccine and intranasal delivery technology: induction of systemic and mucosal immune responses in rats.
    Huang J, Garmise RJ, Crowder TM, Mar K, Hwang CR, Hickey AJ, Mikszta JA, Sullivan VJ.
    Vaccine; 2004 Dec 21; 23(6):794-801. PubMed ID: 15542204
    [Abstract] [Full Text] [Related]

  • 18. Phase 1 evaluation of intranasal virosomal influenza vaccine with and without Escherichia coli heat-labile toxin in adult volunteers.
    Glück U, Gebbers JO, Glück R.
    J Virol; 1999 Sep 21; 73(9):7780-6. PubMed ID: 10438868
    [Abstract] [Full Text] [Related]

  • 19. Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine.
    Clements ML, Murphy BR.
    J Clin Microbiol; 1986 Jan 21; 23(1):66-72. PubMed ID: 3700610
    [Abstract] [Full Text] [Related]

  • 20. A dose-response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults.
    Atmar RL, Keitel WA, Cate TR, Munoz FM, Ruben F, Couch RB.
    Vaccine; 2007 Jul 20; 25(29):5367-73. PubMed ID: 17559990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.